JP2024144435A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024144435A5 JP2024144435A5 JP2024111946A JP2024111946A JP2024144435A5 JP 2024144435 A5 JP2024144435 A5 JP 2024144435A5 JP 2024111946 A JP2024111946 A JP 2024111946A JP 2024111946 A JP2024111946 A JP 2024111946A JP 2024144435 A5 JP2024144435 A5 JP 2024144435A5
- Authority
- JP
- Japan
- Prior art keywords
- aav
- bioreactor
- genes encoding
- perfusion
- perfusion culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20209811.7 | 2020-11-25 | ||
| EP20209811.7A EP4006141A1 (en) | 2020-11-25 | 2020-11-25 | Method for the production of aav |
| JP2022569478A JP7601339B2 (ja) | 2020-11-25 | 2021-11-23 | Ａａｖを産生する方法 |
| PCT/EP2021/082615 WO2022112218A1 (en) | 2020-11-25 | 2021-11-23 | Method for the production of aav |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022569478A Division JP7601339B2 (ja) | 2020-11-25 | 2021-11-23 | Ａａｖを産生する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024144435A JP2024144435A (ja) | 2024-10-11 |
| JP2024144435A5 true JP2024144435A5 (enExample) | 2025-04-02 |
Family
ID=73597941
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022569478A Active JP7601339B2 (ja) | 2020-11-25 | 2021-11-23 | Ａａｖを産生する方法 |
| JP2024111946A Pending JP2024144435A (ja) | 2020-11-25 | 2024-07-11 | Ａａｖを産生する方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022569478A Active JP7601339B2 (ja) | 2020-11-25 | 2021-11-23 | Ａａｖを産生する方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20240263148A1 (enExample) |
| EP (3) | EP4006141A1 (enExample) |
| JP (2) | JP7601339B2 (enExample) |
| KR (1) | KR102700433B1 (enExample) |
| CN (1) | CN116209748A (enExample) |
| AU (1) | AU2021388811B2 (enExample) |
| CA (1) | CA3174017C (enExample) |
| DK (1) | DK4107252T3 (enExample) |
| ES (1) | ES3017247T3 (enExample) |
| FI (1) | FI4107252T3 (enExample) |
| IL (1) | IL296770B2 (enExample) |
| MX (1) | MX2022013385A (enExample) |
| PT (1) | PT4107252T (enExample) |
| WO (1) | WO2022112218A1 (enExample) |
| ZA (1) | ZA202210745B (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024537896A (ja) | 2021-10-18 | 2024-10-16 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | アデノウイルス随伴ウイルスポリヌクレオチドを含む真核細胞 |
| EP4490278A1 (en) * | 2022-03-07 | 2025-01-15 | Ultragenyx Pharmaceutical Inc. | Modified batch aav production systems and methods |
| WO2023232922A1 (en) * | 2022-06-03 | 2023-12-07 | F. Hoffmann-La Roche Ag | Method for producing recombinant aav particles |
| WO2025047766A1 (ja) | 2023-08-29 | 2025-03-06 | 富士フイルム株式会社 | ウイルスの製造方法および細胞への核酸導入方法 |
| WO2025171001A1 (en) | 2024-02-06 | 2025-08-14 | Regeneron Pharmaceuticals, Inc. | Compositions and methods for improved production of aav viral vectors |
| WO2025168663A1 (en) | 2024-02-09 | 2025-08-14 | F. Hoffmann-La Roche Ag | Method for producing recombinant adeno-associated viral particles |
| EP4606816A1 (en) * | 2024-02-26 | 2025-08-27 | Universitat Autónoma De Barcelona (UAB) | Method for production of gene therapy vehicles in mammalian cells |
| WO2025226558A1 (en) | 2024-04-22 | 2025-10-30 | Ultragenyx Pharmaceutical Inc. | Multi-step filtration and clarification methods for recombinant adeno-associated virus purification |
| WO2025252480A1 (en) | 2024-06-07 | 2025-12-11 | F. Hoffmann-La Roche Ag | Method for purifying plasmid dna |
| WO2026010979A2 (en) * | 2024-07-01 | 2026-01-08 | Genzyme Corporation | Perfusion in production bioreactors |
| US20260022401A1 (en) | 2024-07-22 | 2026-01-22 | Hoffmann-La Roche Inc. | Novel AAV rep ORFs and Rep polypeptides |
| WO2026037757A1 (en) | 2024-08-13 | 2026-02-19 | F. Hoffmann-La Roche Ag | Modified aav particles |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020168342A1 (en) * | 1994-11-03 | 2002-11-14 | Cell Genesys, Inc. | Novel adenoviral vectors, packaging cell lines, recombinant adenoviruses and methods |
| US6989264B2 (en) * | 1997-09-05 | 2006-01-24 | Targeted Genetics Corporation | Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
| JP2002528087A (ja) * | 1998-10-27 | 2002-09-03 | クルセル ホランド ベー ヴェー | 改良ａａｖベクター産生 |
| US6844192B2 (en) * | 2001-06-29 | 2005-01-18 | Wake Forest University | Adenovirus E4 protein variants for virus production |
| CA3018264A1 (en) * | 2016-04-12 | 2017-10-19 | Artemis Biosystems, Inc. | Perfusion filtration systems |
| EP3456822A1 (en) * | 2017-09-19 | 2019-03-20 | CEVEC Pharmaceuticals GmbH | Inducible aav rep genes |
| EP3914696A4 (en) * | 2019-01-25 | 2022-12-14 | Biogen MA Inc. | SEED CULTIVATION METHOD FOR THE PRODUCTION OF AAV |
| US20220243225A1 (en) * | 2019-04-29 | 2022-08-04 | Voyager Therapeutics, Inc. | SYSTEMS AND METHODS FOR PRODUCING BACULOVIRAL INFECTED INSECT CELLS (BIICs) IN BIOREACTORS |
-
2020
- 2020-11-25 EP EP20209811.7A patent/EP4006141A1/en not_active Withdrawn
-
2021
- 2021-11-23 AU AU2021388811A patent/AU2021388811B2/en active Active
- 2021-11-23 JP JP2022569478A patent/JP7601339B2/ja active Active
- 2021-11-23 CN CN202180045906.3A patent/CN116209748A/zh active Pending
- 2021-11-23 DK DK21811385.0T patent/DK4107252T3/da active
- 2021-11-23 MX MX2022013385A patent/MX2022013385A/es unknown
- 2021-11-23 US US18/005,027 patent/US20240263148A1/en active Pending
- 2021-11-23 PT PT218113850T patent/PT4107252T/pt unknown
- 2021-11-23 ES ES21811385T patent/ES3017247T3/es active Active
- 2021-11-23 EP EP25158433.0A patent/EP4596674A3/en active Pending
- 2021-11-23 KR KR1020227040149A patent/KR102700433B1/ko active Active
- 2021-11-23 EP EP21811385.0A patent/EP4107252B1/en active Active
- 2021-11-23 WO PCT/EP2021/082615 patent/WO2022112218A1/en not_active Ceased
- 2021-11-23 FI FIEP21811385.0T patent/FI4107252T3/fi active
- 2021-11-23 IL IL296770A patent/IL296770B2/en unknown
- 2021-11-23 CA CA3174017A patent/CA3174017C/en active Active
-
2022
- 2022-09-28 ZA ZA2022/10745A patent/ZA202210745B/en unknown
-
2024
- 2024-07-11 JP JP2024111946A patent/JP2024144435A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024144435A5 (enExample) | ||
| FI4107252T3 (fi) | Menetelmä aav:n valmistamiseksi | |
| JP6165752B2 (ja) | アデノ随伴ウイルスの産生のための細胞株 | |
| JP2021118724A5 (enExample) | ||
| JP2018510648A5 (enExample) | ||
| US20250263746A1 (en) | Method for producing recombinant aav particles | |
| JPWO2020081490A5 (enExample) | ||
| JPWO2021011029A5 (enExample) | ||
| RU2850334C1 (ru) | Способ получения aav | |
| WO2022125601A1 (en) | Cell lines for production of adeno-associated virus | |
| JPWO2021167919A5 (enExample) | ||
| WO2025171001A1 (en) | Compositions and methods for improved production of aav viral vectors | |
| RU2025132783A (ru) | СПОСОБЫ УЛУЧШЕНИЯ ПРОДУЦИРОВАНИЯ rAAV | |
| HK40117756A (zh) | 用於生产重组aav颗粒的方法 | |
| RU2025127724A (ru) | Молекула нуклеиновой кислоты, содержащая асимметрично модифицированный ITR для повышения уровня экспрессии встроенного гена, и ее применение | |
| BR122024005920A2 (pt) | Método para a produção de vírus adeno-associado (aav) e aav obtido pelo mesmo | |
| CN120835797A (zh) | 用于产生重组aav颗粒制备物的方法 | |
| BR112022022055B1 (pt) | Método para a produção de vírus adeno-associado (aav) |